Results 121 to 130 of about 44,822 (222)

Klebsiella Lytic Phages Induce Pseudomonas aeruginosa PAO1 Biofilm Formation

Viruses
Bacterial biofilms, characterized by complex structures, molecular communication, adaptability to environmental changes, insensitivity to chemicals, and immune response, pose a big problem both in clinics and in everyday life. The increasing bacterial resistance to antibiotics also led to the exploration of lytic bacteriophages as alternatives ...
Grzegorz Guła, Grazyna Majkowska-Skrobek, Anna Misterkiewicz, Weronika Salwińska, Tomasz Piasecki, Zuzanna Drulis-Kawa   +5 more
openaire   +2 more sources

Therapeutic Optimization of Pseudomonas aeruginosa Phages: From Isolation to Directed Evolution

Viruses
Pseudomonas aeruginosa is a major opportunistic pathogen with high levels of antibiotic resistance. Phage therapy represents a promising alternative for the treatment of difficult infections both alone and in combination with antibiotics.
Sara Bolognini, Caterina Ferretti, Claudia Campobasso, Elisabetta Trovato, Magda Marchetti, Laura Rindi, Arianna Tavanti, Mariagrazia Di Luca   +7 more
doaj   +1 more source

Characterization and genome analysis of lytic Vibrio phage VPK8 with potential in lysing Vibrio parahaemolyticus isolates from clinical and seafood sources

Virology Journal
Background Vibrio parahaemolyticus is a marine bacterium causing seafood-associated gastrointestinal illness in humans and acute hepatopancreatic necrosis disease (AHPND) in shrimp.
Valalak Jintasakul, Jiranan Pattano, Sutima Preeprem, Pimonsri Mittraparp-arthorn   +3 more
doaj   +1 more source

Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in Pseudomonas aeruginosa. [PDF]

Front Cell Infect Microbiol, 2023
García-Cruz JC, Rebollar-Juarez X, Limones-Martinez A, Santos-Lopez CS, Toya S, Maeda T, Ceapă CD, Blasco L, Tomás M, Díaz-Velásquez CE, Vaca-Paniagua F, Díaz-Guerrero M, Cazares D, Cazares A, Hernández-Durán M, López-Jácome LE, Franco-Cendejas R, Husain FM, Khan A, Arshad M, Morales-Espinosa R, Fernández-Presas AM, Cadet F, Wood TK, García-Contreras R.   +24 more
europepmc   +1 more source

A lytic phage to control multidrug-resistant avian pathogenic Escherichia coli (APEC) infection. [PDF]

Front Cell Infect Microbiol, 2023
Yao L, Bao Y, Hu J, Zhang B, Wang Z, Wang X, Guo W, Wang D, Qi J, Tian M, Bao Y, Li H, Wang S.   +12 more
europepmc   +1 more source

ALTERNATIVES TO ANTIBIOTICS: PHAGE LYTIC ENZYMES AND PHAGE THERAPY [PDF]

Bulletin of Russian State Medical University, 2018
openaire   +1 more source

Isolation, characterization and application of a lytic phage vB_VspM_VS1 against Vibrio splendidus biofilm. [PDF]

PLoS One, 2023
Duan X, Jiang L, Guo M, Li C.
europepmc   +1 more source

A broad-host-range lytic phage vB_VhaS-R18L as a candidate against vibriosis. [PDF]

Front Microbiol, 2023
Cai L, Tian Y, Li Z, Yang Y, Ai C, Zhang R.   +5 more
europepmc   +1 more source

Characterization and Genomic Analysis of a Novel Lytic Phage DCp1 against Clostridium perfringens Biofilms. [PDF]

Int J Mol Sci, 2023
Tang Z, Li X, Wang X, Zhang C, Zou L, Ren H, Liu W.   +6 more
europepmc   +1 more source

A capsule-dependent lytic phage for targeting multidrug-resistant and hypervirulent <i>Klebsiella pneumoniae</i>. [PDF]

Appl Environ Microbiol
Tian Z, Gan L, Feng J, Xue G, Du B, Cui J, Yan C, Zhao H, Feng Y, Fan Z, Fu T, Xu Z, Yu Z, Yang Y, Yuehua K, Cui X, Tang Z, Yuan J.   +17 more
europepmc   +1 more source